Park Avenue Securities »

SPDR S&P Biotech shares owned by Park Avenue Securities

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Park Avenue Securities from 13F filings

Historical chart of Park Avenue Securities investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Park Avenue Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Park Avenue Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.6M 47k 98.79
2024-06-30 $331k 3.6k 92.67
2022-12-31 $292k 3.5k 82.93
2022-09-30 $255k 3.2k 79.29
2022-06-30 $202k 2.7k 74.16

More positions owned by Park Avenue Securities

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Eafe Value Etf (EFV)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Msci Emrg Chn (EMXC)
Ishares Tr Mbs Etf (MBB)
Ishares Tr U.s. Tech Etf (IYW)
Ishares Tr National Mun Etf (MUB)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)

View all positions for Park Avenue Securities

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Bank of America Corporation
Citigroup
Citadel Advisors
Morgan Stanley
Millennium Management
Bnp Paribas Arbitrage, Snc
Susquehanna International
Healthcare Of Ontario Pension Plan Trust Fund
Twin Tree Management
Parallax Volatility Advisers
Logos Global Management
Balyasny Asset Management
Wells Fargo & Company

View all funds holding SPDR S&P Biotech